Fermenta Biotech share news, announcements and annual reports
NSE: FERMENTABSE: 506414Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹439.10.
30 Oct: open ₹439.00, high ₹440.75, low ₹411.30
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,229 Cr1,508th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.03
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.90%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.27
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 42,29254.6% delivered
Fermenta Biotech has 82 announcements on record, routine notices left out; 3 in the 30 days to 31 Oct 2026, the latest on 29 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Fermenta Biotech quarterly results
The board meets on 5 Nov 2026 to consider financial results
Notice filed 29 Oct 2026
Fermenta Biotech annual reports, presentations and earnings calls
The company's own documents, latest first.Fermenta Biotech financials, year by year
Annual reports1
- Annual report, year to Mar 202620 Jul 2026
Investor presentations7
- Presentation to be made for shareholders at 74th Annual General Meeting of the Company.11 Aug 2026
- Investor Presentation11 Aug 2026
- Investor presentation for Q4/FY2628 May 2026
- Intimation of Investor Presentation - Q3/9moFY2611 Feb 2026
- Investor presentation H1/FY2612 Nov 2025
2 earlier presentations
Fermenta Biotech share news and announcements
Newest first. Page 1 of 2.
Oct 2026
12 Oct · Analysts
1 Oct · Analysts
Sep 2026
29 Sep · Analysts
24 Sep · Analysts
21 Sep · Analysts
17 Sep · Analysts
Aug 2026
27 Aug · Analysts
17 Aug · Analysts
17 Aug · Rating
11 Aug · General Updates
11 Aug · Meeting
10 Aug · Analysts
Jul 2026
24 Jul · Analysts
20 Jul · Business Responsibility and Sustainability Reporting (BRSR)
17 Jul · Analysts
17 Jul · Analysts
17 Jul · Legal
3 Jul · Approval From Food Safety And Standards Authority Of India (FSSAI) For Company'S Product Vitamin D3 (Cholecalciferol) - Plant Source.
Jun 2026
22 Jun · Analysts
17 Jun · Analysts
9 Jun · Analysts
8 Jun · Analysts
May 2026
26 May · Business
26 May · Intimation Under Regulation 30 And Other Applicable Provisions Of SEBI Listing Regulations
25 May · Analysts
Apr 2026
28 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
21 Apr · Admission Of Company's Shares By NSE Under 'Permitted To Trade' Category On National Stock Exchange (Capital Market Segment).
Feb 2026
19 Feb · Analysts
9 Feb · Business
Dec 2025
24 Dec · Business
How the price met the news
The first session after each announcement, beside the market. Moves to 1 Jan 2026 are on BSE closes, before the company traded on NSE.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 18 Aug 2026Credit ratingdown 0.62%−0.2 pts vs Nifty 500market median 0.0% · five sessions +3.9% (+4.2 pts vs Nifty 500) · volume 0.5× usual · delivery −0.3 pts against usual · The announcement
- 11 Aug 2026Resultsdown 11.70%−11.4 pts vs Nifty 500market median −0.7% · five sessions −16.6% (−15.8 pts vs Nifty 500) · volume 5.3× usual · delivery −17.1 pts against usual · The announcement
- 21 Jul 2026Board or managers changeddown 1.86%−1.9 pts vs Nifty 500market median 0.0% · five sessions −0.4% (+0.4 pts vs Nifty 500) · volume 0.1× usual · delivery +9.0 pts against usual · The announcement
- 27 May 2026Dividendup 2.42%+2.1 pts vs Nifty 500market median 0.0% · five sessions +10.1% (+12.1 pts vs Nifty 500) · volume 1.2× usual · delivery −6.0 pts against usual · The announcement
- 26 May 2026Dividenddown 5.49%−5.3 pts vs Nifty 500market median 0.0% · five sessions +2.6% (+4.4 pts vs Nifty 500) · volume 4.8× usual · delivery +12.0 pts against usual · The announcement
- 1 Jan 2026Order receivedup 0.50%+0.3 pts vs Nifty 500market median +1.1% · five sessions −1.4% (−2.0 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 3 Oct 2025Credit ratingup 0.85%+0.4 pts vs Nifty 500market median 0.0% · five sessions −7.9% (−9.2 pts vs Nifty 500) · volume 0.2× usual · The announcement
Fermenta Biotech results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.